# SPRR2F

## Overview
SPRR2F is a gene that encodes the small proline-rich protein 2F, a member of the SPRR family, which is integral to the formation of the cornified cell envelope in epithelial cells. This protein is categorized as a structural protein, playing a significant role in keratinocyte differentiation and contributing to the skin's barrier function. The SPRR2F protein is involved in cellular defense mechanisms, particularly in response to oxidative stress, and is expressed in various tissues, including the kidney, uterus, esophagus, and bladder. Its expression is notably upregulated in response to tissue injury, suggesting a role in tissue repair and protection against environmental stressors (Huynh2020Sprr2f; Cabral2001Structural). The gene's involvement in oxidative stress response and its implications in diseases such as melanoma and renal ischemia/reperfusion injury highlight its clinical significance (Su2019Identification; GuoHu2020A).

## Function
SPRR2F (small proline-rich protein 2F) is a member of the SPRR family, which plays a crucial role in the formation of the cornified cell envelope in epithelial cells. This protein family is involved in keratinocyte differentiation, contributing to the skin's barrier function and protecting against environmental stressors (Cabral2001Structural). SPRR2F is highly expressed in tissues such as the kidney, uterus, esophagus, and bladder, and its expression is induced in response to tissue injury (Huynh2020Sprr2f).

In healthy cells, SPRR2F is believed to function as a cross-bridging agent within the cornified cell envelope, affecting its biomechanical properties. The concentration and structure of SPRR proteins, including SPRR2F, influence these properties, with tissue-specific requirements dictating the use of specific classes (Cabral2001Structural). SPRR2F is also involved in the oxidative stress response, where it helps protect against reactive oxygen species (ROS)-induced damage. This protective role is particularly evident in renal tissues, where SPRR2F modulates oxidative stress and collagen deposition, which are critical in the context of renal injury (Huynh2020Sprr2f). The protein is active in the cytoplasm and cell membrane, where it contributes to cellular defense mechanisms against oxidative damage (Huynh2020Sprr2f).

## Clinical Significance
SPRR2F has been implicated in several diseases and conditions due to alterations in its expression levels. In melanoma, SPRR2F is one of the genes used to calculate a genetic risk score that predicts disease progression and overall survival. This score serves as an independent risk factor for melanoma outcomes, highlighting the gene's potential role in cancer prognosis (GuoHu2020A). In renal ischemia/reperfusion injury (IRI), SPRR2F is significantly upregulated, suggesting its involvement in processes such as keratinocyte differentiation and tissue repair. This upregulation indicates that SPRR2F may serve as a biomarker for renal IRI, which is a critical factor in kidney transplantation outcomes (Su2019Identification).

In urothelial carcinoma, SPRR2F is part of a gene signature associated with poor prognosis, particularly in tumors exhibiting squamous differentiation. This association suggests that SPRR2F may play a role in the keratinization process linked to adverse outcomes in this type of cancer (Lindgren2012Integrated). These findings underscore the clinical significance of SPRR2F in various pathological conditions, particularly in cancer and tissue injury contexts.


## References


[1. (Huynh2020Sprr2f) Kieu My Huynh, Anny Chuu-Yun Wong, Bo Wu, Marc Horschman, Hongjuan Zhao, and James D. Brooks. Sprr2f protects against renal injury by decreasing the level of reactive oxygen species in female mice. American Journal of Physiology-Renal Physiology, 319(5):F876–F884, November 2020. URL: http://dx.doi.org/10.1152/ajprenal.00318.2020, doi:10.1152/ajprenal.00318.2020. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.00318.2020)

2. (GuoHu2020A) A new genetic method to predict the prognostic outcome of melanoma. This article has 0 citations.

[3. (Su2019Identification) Ming Su, Xinyi Hu, Jun Lin, Lei Zhang, Wen Sun, Jian Zhang, Ye Tian, and Wei Qiu. Identification of candidate genes involved in renal ischemia/reperfusion injury. DNA and Cell Biology, 38(3):256–262, March 2019. URL: http://dx.doi.org/10.1089/dna.2018.4551, doi:10.1089/dna.2018.4551. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/dna.2018.4551)

[4. (Lindgren2012Integrated) David Lindgren, Gottfrid Sjödahl, Martin Lauss, Johan Staaf, Gunilla Chebil, Kristina Lövgren, Sigurdur Gudjonsson, Fredrik Liedberg, Oliver Patschan, Wiking Månsson, Mårten Fernö, and Mattias Höglund. Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma. PLoS ONE, 7(6):e38863, June 2012. URL: http://dx.doi.org/10.1371/journal.pone.0038863, doi:10.1371/journal.pone.0038863. This article has 167 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0038863)

[5. (Cabral2001Structural) Adriana Cabral, Patrick Voskamp, Anne-Marie Cleton-Jansen, Andrew South, Dean Nizetic, and Claude Backendorf. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. Journal of Biological Chemistry, 276(22):19231–19237, June 2001. URL: http://dx.doi.org/10.1074/jbc.m100336200, doi:10.1074/jbc.m100336200. This article has 135 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m100336200)